1. Novel dual-flow perfusion bioreactor for in vitro pre-screening of nanoparticles delivery: design, characterization and testing
- Author
-
Francesco Carfì Pavia, Emanuela Fabiola Craparo, Gennara Cavallaro, Maria Elena Lombardo, Valerio Brucato, Elisa Capuana, Vincenzo La Carrubba, Lombardo M.E., Carfi Pavia F., Craparo E.F., Capuana E., Cavallaro G., Brucato V., and La Carrubba V.
- Subjects
Scaffold ,Materials science ,Polymers ,Diffusion ,Nanoparticle ,Biocompatible Materials ,Bioengineering ,In Vitro Techniques ,3D Scaffold ,Bioreactors ,Fluid dynamics ,Polymeric fluorescent nanoparticles ,Bioreactor ,Animals ,Humans ,Dual-flow perfusion bioreactor ,Porosity ,Drug Carriers ,Settore ING-IND/24 - Principi Di Ingegneria Chimica ,Tissue Engineering ,Tunable radial flow ,Settore ING-IND/34 - Bioingegneria Industriale ,General Medicine ,Microporous material ,Hagen–Poiseuille equation ,Settore CHIM/09 - Farmaceutico Tecnologico Applicativo ,Permeability (electromagnetism) ,Microscopy, Electron, Scanning ,Nanoparticles ,Biotechnology ,Biomedical engineering - Abstract
An advanced dual-flow perfusion bioreactor with a simple and compact design was developed and evaluated as a potential apparatus to reduce the gap between animal testing and drug administration to human subjects in clinical trials. All the experimental tests were carried out using an ad hoc Poly Lactic Acid (PLLA) scaffold synthesized via Thermally Induced Phase Separation (TIPS). The bioreactor shows a tunable radial flow throughout the microporous matrix of the scaffold. The radial perfusion was quantified both with permeability tests and with a mathematical model, applying a combination of Darcy's Theory, Bernoulli's Equation, and Poiseuille's Law. Finally, a diffusion test allowed to investigate the efficacy of the radial flow using Polymeric Fluorescent Nanoparticles (FNPs) mimicking drug/colloidal carriers. These tests confirmed the ability of our bioreactor to create a uniform distribution of particles inside porous matrices. All the findings candidate our system as a potential tool for drug pre-screening testing with a cost and time reduction over animal models.
- Published
- 2021